News Archive
CONTRAVAC'S OTC MALE-FERTILITY TEST WILL SOON BE AVAILABLE IN DRUGSTORES (1/14/12)
ARCHITECT MAGAZINE FEATURES STORY ON PRACTICE AND ACADEMY (6.29.11)
TAU THERAPEUTICS 'PITCH AND RESPONSE' FEATURED IN THE WASHINGTON POST (6.19.11)
SERIES ON THE EMERGING BIOTECH SECTOR FEATURES UVA START-UPS (6.19.11)
UVA INNOVATORS LEAD THE WAY AT CBIC AWARDS CEREMONY (6.15.11)
TAU THERAPEUTICS NAMED FINALIST FOR VA BIOSCIENCE COMPANY OF THE YEAR (5.18.11)
T100 COMPANY LAUNCHES FIRST PRODUCT FOR FASTER DNA EXTRACTION (5.15.11)
PHTHISIS DIAGNOSTICS RAISES SERIES A FUNDING (4.26.11)
WellAWARE SYSTEMS SELECTED AS VA HEALTHCARE INNOVATOR OF THE YEAR (4.7.11)
UVA'S VENTURE SUMMIT INTERACTIVE SHOWCASE (3.14.11)
INITIATIVE RECOVER WINS INTERNATIONAL HOUSING FOR HAITI COMPETITION (1.13.11)
GLOBAL CELL SOLUTIONS (GCS) PARTNERS WITH BD BIOSCIENCES (12.10.10)
T100 COMPANIES SNAG GRANTS UNDER THE QUALIFYING THERAPEUTIC DISCOVERY PROJECT TAX CREDIT PROGRAM (11.01.10)
SE BIO SELECTS HEMOSONICS TO PRESENT AT INVESTOR FORUM (10.20.10)
TAU THERAPEUTICS CHOSEN TO PRESENT AT MID-ATLANTIC BIO (10.18.10)
HEMOSONICS SECURES FEDERAL FUNDING (10.7.10)
T100 COMPANY HELPING TO ADDRESS URGENT SECURITY NEEDS (9.24.10)
PLUROGEN SIGNS $8.6M CONTRACT WITH DEPT. OF DEFENSE (9.1.10)
RECIPIENT OF T100 FUNDING RECOGNIZED AS ONE OF WORLD'S TOP YOUNG INNOVATORS (8.27.10)
T100 COMPANIES INCLUDED IN NATIONAL REPORT ON 'SPARKING ECONOMIC GROWTH' (6.17.10)
CONTRAVAC RECEIVES FDA APPROVAL FOR AT-HOME MALE FERTILITY TEST (6.14.10)
MICROLAB AND ZYGEM JOIN FORCES (6.8.10)
T100 INNOVATORS HONORED AT LOCAL AWARDS CEREMONY (6.2.10)
FOUNDER OF T100 COMPANY NAMED "CO-INVENTOR OF THE YEAR" (4.6.10)
"EARLY STAGE DEAL OF THE YEAR" RUNNER-UP HAS ROOTS IN T1OO (3.12.10)
SPERMCHECK FERTILITY FEATURED IN LEAD COVER ARTICLE (2.2.10)
BENCHTOP BIOLEVITATOR HAILED AS TOP 10 INNOVATION FOR 2009 (1.05.10)
DIAKINE NAMED A TOP INNOVATOR BY YOUNGSTARTUP VENTURES (12.08.09)
COMPANY WITH T100 ROOTS SECURES $7.5 MILLION IN GROWTH CAPITAL (12.07.09)
PLUROGEN AND U.VA. PARTNER ON NIH STTR GRANT (10.25.09)
TAU THERAPEUTICS ADVANCES BRAIN CANCER TREATMENTS (10.3.09)
BETTER WORLD REPORT FEATURES T100 COMPANIES (6.29.09)
PLUROGEN MAKES COMMERCIAL ADVANCES (6.15.09)
T100 COMPANIES RECOGNIZED AS INNOVATION LEADERS (5.22.09)
FOUNDER OF GLOBAL CELL SOLUTIONS RECEIVES 2009 ENGELBERGER AWARD IN LEADERSHIP (4.8.09)
ADVANCES MADE IN TYPE 2 DIABETES TREATMENT (1.22.09)
T100 COMPANY RECEIVES FDA APPROVAL TO TREAT PANCREATIC CANCER (12.17.08)
HEMOSONICS SELECTED AS FINALIST IN SE BIO SHOOT-OUT (12.16.08)
CLINICAL AND CONSUMER TRIALS SUPPORT T100 TECHNOLOGY (11.07.08)
DIRECTED VAPOR TECHNOLOGIES INT'L (DVTI) OPENS MANUFACTURING FACILITY IN CHARLOTTESVILLE
T100 MENTOR DISCUSSES EXECUTIVE COMPENSATION AT U.VA. TECHNOLOGY COMMERCIALIZATION EVENT (11.13.08)
DIAKINE THERAPEUTICS ENTERS PHASE II CLINICAL TRIALS (10.14.08)
BLUETREE ALLIED ANGELS INVEST IN T100 COMPANY (9.03.08)
PHTHISIS RECEIVES NIH FUNDING (7.24.08)
T100 COMPANY PRESENTS RESULTS FOR REVERSING TYPE I DIABETES (6.10.08)
FOUNDER OF T100 COMPANY, PLUROGEN THERAPEUTICS, NAMED U.VA. INVENTOR OF THE YEAR (5.08.08)
U.VA. PATENT FOUNDATION LICENSES SILVER NANOPARTICLE TECHNOLOGY TO U.VA. START-UP PLUROGEN THERAPEUTICS INC. (04.21.08)
STATE FUND BACKS U.VA. RESEARCH WITH COMMERCIAL POTENTIAL (03.31.08)
HOME GUARDIAN RELEASES INNOVATIVE SENSOR SYSTEM TO KEEP SENIORS SAFE (03.27.08)
CONTRAVAC RECEIVES FDA APPROVAL (03.03.08)
LAB AUTOMATION AWARD FOR T100 TECHNOLOGY (02.07.08)
HEALING ORTHOPAEDIC TECHNOLOGIES FOUNDER RECOGNIZED FOR ACL BREAKTHROUGHS (01.02.08)
PLUROGEN THERAPEUTICS PARTNERS WITH WELCARE INDUSTRIES (12.27.07)
NIH TO SPONSOR STUDY OF DIAKINE DRUG (10.09.07)
T100 COMPANIES IDENTIFIED AS GROWTH COMPANIES (09.25.07)
POCKETSONICS GRADUATES WITH CLEAR VISION FOR THE FUTURE (07.02.07)
DIAKINE THERAPEUTICS HONORED WITH BREAKTHROUGH AWARD (06.12.07)
GLOBAL CELL SOLUTIONS (GCS) ANNOUNCES PARTNERSHIP (05.18.07)
PLUROGEN RAISES $1.7M SEED, RAISING $7M SERIES A (04.13.07)
MICROLAB DIAGNOSTICS RECOGNIZED AS "BEST IN LIFE SCIENCES" (03.26.07)
TAU THERAPEUTICS NAMED ONE OF THE TOP 15 "BEST AND BRIGHTEST BIOTECHNOLOGY COMPANIES" IN THE SE (03.02.07)
TAU THERAPEUTICS CLOSES $500K ANGEL FUNDING (02.08.07)
|
